Khaldoon Al Mubarak, chief executive and managing director of Mubadala and board member of Group42, pictured second from left, attends the launch in Belgrade
Khaldoon Al Mubarak, chief executive and managing director of Mubadala and board member of Group42, pictured second from left, attends the launch in Belgrade

UAE

Work begins on Sinopharm vaccine plant in Serbia in tie-up with UAE

Project is a partnership between Group42, Sinopharm CNBG, the Republic of Serbia and Hayat Biotech

Gillian Duncan
Gillian Duncan

September 13, 2021